Inventiva IVA
NASDAQ IVA
$3.95 +0.12 (+2.99%)
As of: Nov 10, 2026 · 3:51 PM EST

Inventiva (IVA) EBIT Margin (2020 - 2021)

Updated

Inventiva (IVA) posted EBIT Margin of -3145.51% for FY2025, down 2084.86 percentage points from -1060.64% in FY2024.

Analysis

Inventiva (IVA) EBIT Margin (2020 - 2021) Analysis & Trends

Since FY2018, Inventiva has reported EBIT Margin for 8 years.

  • Annual EBIT Margin has declined for three consecutive years, though with a five-year change of +4843.20 percentage points (FY2020 to FY2025).
  • The FY2025 figure stands as the lowest annual EBIT Margin since FY2020.
  • Business Quant data shows IVA's EBIT Margin at -1060.64% in FY2024 (-472.96 pp), -587.68% in FY2023 (-118.76 pp), -468.92% in FY2022 (+773.66 pp) and -1242.58% in FY2021 (+6746.13 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 52.42%
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 24.35%
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 36.01%
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 30.89%
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 32.97%
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 20.57%
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 35.79%
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 41.71%
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 32.98%
10 Inventiva 732.26 Mn 182.20 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -21,021.54%
Mar 31, 2021 -13,435.14%
Jun 30, 2020 -11,972.97%
Mar 31, 2020 -7,821.84%
API Access

Inventiva EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=IVA&period=max&api_key=YOUR_API_KEY